News

The company has developed the anti malarial drug by utilizing its Dose Optimization Technology under the Novel Drug Delivery System (NDDS). ARH 1 carries Arteether 150mg/ml and is

Under the agreement, Unigene is expected utilize its peptide manufacturing technology to offer clinical supply material for a Phase 3 study of experimental drug CR845, to be conducted

The milestone payment triggers from the initiation of a Phase 1 clinical trial of ISIS-TTRRx, an antisense drug, by Isis Pharma to treat transthyretin amyloidosis. The agreement allows

The company expects to recruit around 880 patients in 48 hospitals in 9 countries across three continents. The study, named as immunotherapy Multikine anti tumor treatments (IT-MATTERS), is

The new development is particularly suitable for processing highly effective inhalation products within filling ranges of 2-30 milligrams. The GKF 2500 is available with a dosing roller which

The expanded facility features a 90-bed sleeping area, exam and procedure rooms, pharmacy, in-patient and outpatient fully equipped laboratories and attractive and comfortable subject spaces with recreational areas,

Following the acquisition, Phadia will be part of Thermo Fisher’s Specialty Diagnostics business within its Analytical Technologies Segment. Thermo Fisher will leverage Phadia’s clinical marketing model to sell

ShangPharma has reported a net income of $3.01m, or $0.16 per diluted share, compared to net income of $2.73m or $0.18 per diluted share, for the same period

Under the agreement, both the companies will develop fluid systems and market single-use tubing, which will be produced by Raumedic and will supply to SSB. SSB will combine